Respiratory Distress Syndrome (RDS) is a common condition in premature newborns due to their underdeveloped lungs. Surfactant is administered directly into the lungs through a tube to help reduce surface tension and improve lung function. This treatment significantly reduces mortality and complications associated with RDS.
